Mucormycosis and COVID‐19: An epidemic within a pandemic in India
Coronavirus disease (COVID-19) causes an immunosuppressed state and increases risk of secondary infections like mucormycosis. We evaluated clinical features, predisposing factors, diagnosis and outcomes for mucormycosis among patients with COVID-19 infection. This prospective, observational, multi-c...
Shranjeno v:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Jezik: | angleščina |
Izdano: |
2021
|
Online dostop: | https://doi.org/10.1111/myc.13353 |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Komentirajte kot prvi!